Endogenous VEGF-C mRNA Expression Increases In Vitro Drug Resistance of Pediatric AML Cells and Is an Independent Prognostic Factor for the Time To Reach Complete Remission in AML.
Hendrik J.M. de Jonge(University Medical Center Groningen), E. S. J. M. de Bont(University Medical Center Groningen), Bianca F. Goemans(Princess Máxima Center), Frank J.G. Scherpen, Ursula Creutzig(Medizinische Hochschule Hannover), Gertjan J.L. Kaspers(Emma Kinderziekenhuis), Alida C. Weidenaar(University Medical Center Groningen), H. Marike Boezen(University Medical Center Groningen), Willem A. Kamps(Pediatric Oncology Group), Arja ter Elst(University Medical Center Groningen), Jessica C.A. Bouma-ter Steege(Beatrix Kinderziekenhuis)
Cited by 1
Related Papers
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
|The Lancet|1998|964
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
|The Lancet Oncology|2009|932
Evidence Based Selection of Housekeeping Genes
|PLoS ONE|2007|772
Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2000|599